Posts tagged Financing
enGene, Inc. and Forbion European Acquisition Corp. Announce Business Combination Agreement to Create Biotechnology Company
enGene, Inc. and Forbion European Acquisition Corp. Announce Business Combination Agreement to Create Biotechnology Company

enGene, Inc. (“enGene”), a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues, and Forbion European Acquisition Corp. (“FEAC,” Nasdaq: FRBN), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be named “enGene Holdings Inc.” whose common shares are expected to be listed on Nasdaq.

Read More
NewsGuest UserBIOOQuébecenGene, enGene Holdings Inc, Financing
Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease
Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease

“We are pleased to close our first financing and to welcome Frederic Ors as lead investor and strategic advisor to Saguaro. Frederic is a well-recognized executive with a track-record of successfully growing biotech companies,” said Louis Turcotte Co-Founder & Chief Executive Officer. “Frederic shares our vision on the potential of next-generation technologies to make drug discovery more successful and we are looking forward to benefit from his experience and network.”

Read More
NewsGuest UserSaguaro, Financing
Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding
Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding

Company founded in 2021 and led by Clarissa Desjardins, Ph.D., previously the founder and chief executive officer of Clementia Pharmaceuticals (now Ipsen). Kenneth J. Valenzano, Ph.D., joins as Chief Scientific Officer, adding to a team with domain experience in rare disease clinical development, computational and medicinal chemistry, and business development

Read More
NewsCatherine LamontagneCongruence Therpeutics Inc., Financing
MIMS Raises $5M for Expansion into new Markets
MIMS Raises $5M for Expansion into new Markets

Montreal’s My Intelligent Machines (aka MIMS) has raised a second seed round of financing in the amount of $5 million. According to Crunchbase, this is the company’s first raise since the fall of 2019 when it raised $2.6 million. This round was led by MEDTEQ+ and StandUp Ventures, with participation from Desjardins Capital, Anges Québec, Anges Québec Capital and Real Ventures.

Read More
NewsGuest UserMIMS, Financing, $5 million, MEDTEQ+, StandUp Ventures, biological systems, life sciences